{"id":"mixed-salts-amphetamine","safety":{"commonSideEffects":[{"rate":"10-30%","effect":"Insomnia"},{"rate":"10-25%","effect":"Decreased appetite"},{"rate":"5-15%","effect":"Headache"},{"rate":"5-15%","effect":"Nervousness or anxiety"},{"rate":"5-10%","effect":"Tachycardia"},{"rate":"5-10%","effect":"Elevated blood pressure"},{"rate":"5-10%","effect":"Tremor"}]},"_chembl":null,"_dailymed":{"setId":"60a2834c-38a2-480e-b89c-563e9cf0c9c3","title":"MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR (DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [SPECGX LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amphetamine is a sympathomimetic amine that acts as a potent releaser of catecholamines (dopamine and norepinephrine) from presynaptic neurons and inhibits their reuptake via monoamine transporters. This results in increased synaptic concentrations of these neurotransmitters, which enhances alertness, focus, and executive function while reducing hyperactivity and impulsive behavior in patients with attention deficit disorders.","oneSentence":"Mixed salts amphetamine increases the release and blocks the reuptake of dopamine and norepinephrine in the central nervous system, enhancing attention and reducing impulsivity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:30.764Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention-deficit/hyperactivity disorder (ADHD)"},{"name":"Narcolepsy"}]},"trialDetails":[{"nctId":"NCT06853665","phase":"PHASE4","title":"The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine","status":"RECRUITING","sponsor":"Gagan Joshi","startDate":"2026-02-01","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Autism, Autism Spectrum Disorder","enrollment":196},{"nctId":"NCT03511976","phase":"PHASE4","title":"Adaptive Response to Intervention (RTI) for Students With ADHD","status":"WITHDRAWN","sponsor":"Florida International University","startDate":"2018-05-14","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":""},{"nctId":"NCT05536011","phase":"","title":"WAKIX® (Pitolisant) Pregnancy Registry","status":"RECRUITING","sponsor":"Harmony Biosciences Management, Inc.","startDate":"2021-08-24","conditions":"Pregnancy Related, Narcolepsy","enrollment":1329},{"nctId":"NCT05650775","phase":"PHASE1","title":"Biomarkers of ADHD Treatment Response","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2023-02-17","conditions":"ADHD","enrollment":16},{"nctId":"NCT04240756","phase":"PHASE3","title":"Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, College Park","startDate":"2020-08-06","conditions":"ADHD, Parenting","enrollment":240},{"nctId":"NCT02676739","phase":"PHASE2, PHASE3","title":"Adderall XR and Cognitive Impairment in MS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sarah Morrow","startDate":"2016-05-20","conditions":"Multiple Sclerosis","enrollment":180},{"nctId":"NCT04823364","phase":"NA","title":"Evaluation of Brain Neurotransmitter Levels in Adults With ADHD, Before and After Stimulant Treatment","status":"TERMINATED","sponsor":"Weizmann Institute of Science","startDate":"2024-07-11","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":60},{"nctId":"NCT02478788","phase":"PHASE4","title":"Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2015-11","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":153},{"nctId":"NCT02058693","phase":"PHASE4","title":"Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2010-12","conditions":"Major Depressive Disorder","enrollment":41},{"nctId":"NCT01074294","phase":"PHASE2","title":"Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2010-03-16","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":740},{"nctId":"NCT01986075","phase":"PHASE1, PHASE2","title":"A Sequenced Behavioral and Medication Intervention for Cocaine Dependence","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2014-01","conditions":"Cocaine Dependence","enrollment":145},{"nctId":"NCT00746733","phase":"PHASE1","title":"Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC","status":"COMPLETED","sponsor":"Shire","startDate":"2008-09-08","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT01010750","phase":"PHASE1","title":"Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Shire","startDate":"2010-01-05","conditions":"Attention-Deficit Hyperactivity Disorder","enrollment":18},{"nctId":"NCT00506727","phase":"PHASE4","title":"Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD","status":"COMPLETED","sponsor":"Shire","startDate":"2003-08-05","conditions":"ADHD","enrollment":215},{"nctId":"NCT00507065","phase":"PHASE3","title":"Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Shire","startDate":"2003-05-28","conditions":"ADHD","enrollment":329},{"nctId":"NCT00557960","phase":"PHASE3","title":"ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD","status":"COMPLETED","sponsor":"Shire","startDate":"2004-02-25","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":36},{"nctId":"NCT02803229","phase":"PHASE2, PHASE3","title":"Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2016-07","conditions":"Cannabis Use Disorder, Attention-deficit/Hyperactivity Disorder","enrollment":33},{"nctId":"NCT03893032","phase":"PHASE2","title":"Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants","status":"UNKNOWN","sponsor":"United States Army Aeromedical Research Laboratory","startDate":"2019-07-17","conditions":"Cognition","enrollment":80},{"nctId":"NCT00553319","phase":"PHASE2, PHASE3","title":"Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2007-12","conditions":"Adult Attention Deficit Hyperactivity Disorder, Cocaine Dependence","enrollment":139},{"nctId":"NCT00421603","phase":"PHASE2","title":"A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2007-02","conditions":"Cocaine Dependence","enrollment":81},{"nctId":"NCT01399827","phase":"PHASE2","title":"Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2012-02","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Deficient Emotional Self-Regulation (DESR)","enrollment":2},{"nctId":"NCT01070394","phase":"PHASE4","title":"Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2010-02","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":40},{"nctId":"NCT00393042","phase":"PHASE3","title":"Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2006-01","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":77},{"nctId":"NCT01133847","phase":"PHASE4","title":"Interventions for Children With Attention and Reading Disorders","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2010-11","conditions":"Attention Deficit Hyperactivity Disorder, Reading Disabilities","enrollment":222},{"nctId":"NCT00228046","phase":"PHASE4","title":"Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2004-01","conditions":"Attention Deficit Disorder With Hyperactivity, Conduct Disorder, Oppositional Defiant Disorder","enrollment":40},{"nctId":"NCT00889915","phase":"PHASE4","title":"Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)","status":"COMPLETED","sponsor":"Duke University","startDate":"2009-04","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":228},{"nctId":"NCT00712699","phase":"NA","title":"Effectiveness of an Extended Release Stimulant Medication in Treating Preschool Children With ADHD","status":"COMPLETED","sponsor":"Baystate Medical Center","startDate":"2008-06","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":27},{"nctId":"NCT00573859","phase":"PHASE1, PHASE2","title":"The Reinforcing Mechanisms of Smoking in Adult ADHD","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2006-09","conditions":"ADHD","enrollment":27},{"nctId":"NCT00557011","phase":"PHASE2","title":"NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD","status":"COMPLETED","sponsor":"New River Pharmaceuticals","startDate":"2004-09","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":52},{"nctId":"NCT00634439","phase":"","title":"Safety Study of Atomoxetine and Cerebrovascular Outcomes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2008-01","conditions":"Cerebrovascular Accident, Transient Ischemic Attack, ADHD","enrollment":72000}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"HEADACHE"},{"count":2,"reaction":"INSOMNIA"},{"count":1,"reaction":"AMPHETAMINES NEGATIVE"},{"count":1,"reaction":"CONSTIPATION"},{"count":1,"reaction":"DRUG EFFECT VARIABLE"},{"count":1,"reaction":"DRY MOUTH"},{"count":1,"reaction":"EDUCATIONAL PROBLEM"},{"count":1,"reaction":"JOINT STIFFNESS"},{"count":1,"reaction":"PALPITATIONS"},{"count":1,"reaction":"THERAPEUTIC RESPONSE UNEXPECTED"}],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Adderall"],"phase":"marketed","status":"active","brandName":"mixed salts amphetamine","genericName":"mixed salts amphetamine","companyName":"Rush University Medical Center","companyId":"rush-university-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mixed salts amphetamine increases the release and blocks the reuptake of dopamine and norepinephrine in the central nervous system, enhancing attention and reducing impulsivity. Used for Attention-deficit/hyperactivity disorder (ADHD), Narcolepsy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}